The global animal drug compounding market size is expected to reach USD 2.5 Billion by 2030, to expand at a CAGR of 8.19% from 2023 to 2030. The key factors driving the market growth include a rise in pet adoption, huge animal healthcare spending, increased pet owner awareness regarding specialty pharmaceuticals, the high cost of branded veterinary products, pet humanization trends, and an increase in the demand for custom-made, compounded animal medications.
The COVID-19 pandemic had a negative impact on the market for animal drug compounding in 2020, just like on several other global industries. The most significant effects of COVID-19 on the veterinary healthcare system are supply chain disruptions, a drop in sales, a slowdown in demand, and operational challenges brought on by shifting regulations and policies. Manufacturing firms, veterinary pharmacies, and animal care service providers were severely impacted as many areas entered state-wide lockdowns and imposed restrictions on the movement of people and goods. For instance, according to the American veterinary medical association, in April 2020, approximately 60% of veterinary practices were canceled or delayed due to the outbreak of coronavirus and in July 2020, the number of veterinary practices declined to about 30%. Thus, the impact of COVID-19 has hampered market growth.
Compounding veterinary drugs fills the gaps left by less readily available licensed drugs for veterinary treatment and other veterinary medication alternatives. Compounded medications are a better choice for treating a wide range of animal diseases when FDA-approved drugs are difficult to find for certain medical conditions. For instance, chewable tablets are commercially approved products in specific dosage forms and are suggested for use in certain animal species yet are unacceptable for use in animals such as cats or exotic pets. Similarly, widely available medications have an unpleasant taste for some animals limiting the administering rate. In this case, animal drug compounding is preferred, particularly for difficult-to-administer medications.
During the pandemic, pet adoption considerably increased, leading to an increased animal healthcare infrastructure and driving the market for compounded medications for animals. According to a report published by the American Society for the Prevention of Cruelty to Animals (ASPCA) in May 2021, one in every five families had adopted a cat or dog since the COVID-19 pandemic began. The increased focus on pet health brought on by adoptions during the pandemic is expected to drive the expansion of the animal drug compounding market over the coming years.
Similarly, the global animal drug compounding market is expected to expand due to market players focusing on programs and initiatives concerning veterinary health. For instance, in June 2021, Covetrus acquired VCP, a platform for administering veterinary wellness plans that serves about 1,000 practices and presently benefits over 350,000 pets through wellness plans that are enabled by VCP. Covetrus will make use of the infrastructure and technology platform provided by VCP to offer new methods for vets to develop closer bonds with their pet owners and produce better results in terms of both business and healthcare.
The COVID-19 pandemic had a negative impact on the market for animal drug compounding in 2020, just like on several other global industries. The most significant effects of COVID-19 on the veterinary healthcare system are supply chain disruptions, a drop in sales, a slowdown in demand, and operational challenges brought on by shifting regulations and policies. Manufacturing firms, veterinary pharmacies, and animal care service providers were severely impacted as many areas entered state-wide lockdowns and imposed restrictions on the movement of people and goods. For instance, according to the American veterinary medical association, in April 2020, approximately 60% of veterinary practices were canceled or delayed due to the outbreak of coronavirus and in July 2020, the number of veterinary practices declined to about 30%. Thus, the impact of COVID-19 has hampered market growth.
Compounding veterinary drugs fills the gaps left by less readily available licensed drugs for veterinary treatment and other veterinary medication alternatives. Compounded medications are a better choice for treating a wide range of animal diseases when FDA-approved drugs are difficult to find for certain medical conditions. For instance, chewable tablets are commercially approved products in specific dosage forms and are suggested for use in certain animal species yet are unacceptable for use in animals such as cats or exotic pets. Similarly, widely available medications have an unpleasant taste for some animals limiting the administering rate. In this case, animal drug compounding is preferred, particularly for difficult-to-administer medications.
During the pandemic, pet adoption considerably increased, leading to an increased animal healthcare infrastructure and driving the market for compounded medications for animals. According to a report published by the American Society for the Prevention of Cruelty to Animals (ASPCA) in May 2021, one in every five families had adopted a cat or dog since the COVID-19 pandemic began. The increased focus on pet health brought on by adoptions during the pandemic is expected to drive the expansion of the animal drug compounding market over the coming years.
Similarly, the global animal drug compounding market is expected to expand due to market players focusing on programs and initiatives concerning veterinary health. For instance, in June 2021, Covetrus acquired VCP, a platform for administering veterinary wellness plans that serves about 1,000 practices and presently benefits over 350,000 pets through wellness plans that are enabled by VCP. Covetrus will make use of the infrastructure and technology platform provided by VCP to offer new methods for vets to develop closer bonds with their pet owners and produce better results in terms of both business and healthcare.
Animal Drug Compounding Market Report Highlights
- Based on animal type, the companion animals segment accounted for the largest revenue share in 2022. This can be attributed to the increasing adoption of pet animals, the rise in animal expenditure, and the increasing demand for compounding medication for pet animals.
- Based on products, the CNS agents segment dominated with a market share of around 33% in 2022, as CNS agents are the most frequently prescribed medication for treating neurological conditions such as changes in behavior, blindness, seizures, epilepsy, etc., in pets. Hormones & Substitutes is the fastest-growing segment with a rate of over 9.0% since it is better and more potent for hormonal imbalance treatment in animals.
- Among routes of administration, the oral segment held the largest market share of more than 53 % in 2022, as oral formulations are the preferred, easy, and more acceptable route of drug administration. Whereas, topical is the fastest-growing segment among the routes of administration, with a growth rate of over 9.0% during the forecast period.
- Based on dosage form, the suspensions segment accounted for the largest revenue share of about 49% in 2022, as suspensions were the most dispensed compounded dosage form for animals. The Solutions segment is estimated to register the highest CAGR of over 8% in the coming years owing to the several benefits of the solution compared to another solid dosage form. Solutions are usually more GI mucosa-friendly than solid dosage forms as they are more quickly absorbed. In addition, unlike suspensions, phase separation during storing is not an issue with solutions. Thus, solutions are expected to gain popularity during the forecast period.
- North America attributed the largest share of about 40% of the market by region in 2022, owing to an increase in pet ownership together with rising animal health expenditure and high demand for animal drug compounding. While Asia pacific is expected to grow at the fastest CAGR of about 10.0% due to an increase in pet humanization, growing animal healthcare expenditure, and the availability of low-cost animal compounding medications.
Table of Contents
Chapter 1 Research Methodology & Scope1.1 Market Segmentation & Scope
1.1.1 Estimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Market Definition
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.2 Parent Market Analysis
1.8 List of Secondary Sources
1.9 Objectives
Chapter 2 Executive Summary
2.1 Market Snapshot, 2022 (USD Million)
2.2 Segment Snapshot
2.3 Competitive Snapshot
Chapter 3 Animal Drug Compounding Market: Market Variables Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration And Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing Pet Population And High Animal Spending
3.3.1.2 Demand For Customized And Specialized Drugs For Pet Animals
3.3.1.3 Growing Awareness Of The Disease And Available Treatments Among Pet Owners
3.3.1.4 Increase In Compounding Animal Drug Prescriptions
3.3.2 Market Restraint Analysis
3.3.2.1 Risk Associated With Compounding Practices
3.3.2.2 Lack Of Skilled Veterinarians
3.3.3 Market Opportunity Analysis
3.3.4 Market Challenge Analysis
3.4 Industry Analysis
3.4.1 Porter’s Five Forces Analysis
3.4.1.1 Bargaining Power Of Buyers
3.4.1.2 Bargaining Power Of Suppliers
3.4.1.3 Threat Of New Entrants
3.4.1.4 Threat Of Substitutes
3.4.1.5 Industry Rivalry: High
3.4.2 Pestel Analysis
3.4.2.1 Political & Legal Landscape
3.4.2.2 Economic & Social Landscape
3.4.2.3 Environmental Landscape
3.4.2.4 Technology Landscape
3.5 Estimated Animal Population, 2018 - 2022, By Key Species & Key Countries
3.6 Regulatory Landscape
3.7 Pricing Analysis
3.8 User Perspective Analysis
3.8.1 U.S. Pet Owners Demographics, 2022
3.9 Covid-19 Impact Analysis
Chapter 4 Animal Drug Compounding Market: Segment Analysis, By Animal Type, 2018 - 2030 (USD Million)
4.1 Animal Type Market Share Analysis, 2022 & 2030
4.2 Animal Drug Compounding Market, By Animal Type, 2018 To 2030
4.3 Companion Animals
4.3.1 Companion Animals Market, 2018 - 2030 (USD Million)
4.3.2 Dogs
4.3.2.1. Dogs Market, 2018 - 2030 (USD Million)
4.3.3 Cats
4.3.3.1 Cats Market, 2018 - 2030 (USD Million)
4.3.4 Other Animals
4.3.4.1 Other Animals Market, 2018 - 2030 (USD Million)
4.4 Livestock Animals
4.4.1 Livestock Animals Market, 2018 - 2030 (USD Million)
Chapter 5 Animal Drug Compounding Market: Product Estimates & Trend Analysis, 2018 - 2030 (USD Million)
5.1 Product Market Share Analysis, 2022 & 2030
5.2 Animal Drug Compounding Market: Product Key Takeaways, 2018 To 2030
5.3 Anti-Infective Agents
5.3.1 Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4 Anti-Inflammatory Agents
5.4.1 Anti-Inflammatory Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5 Hormones & Substitutes
5.5.1 Hormones & Substitutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6 Cns Agents
5.6.1 Cns Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.7 Others
5.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6 Animal Drug Compounding Market: Route Of Administration Estimates & Trend Analysis, 2018 - 2030 (USD Million)
6.1 Route Of Administration Market Share Analysis, 2022 & 2030
6.2 Animal Drug Compounding Market: Route Of Administration Key Takeaways, 2018 To 2030
6.3 Oral
6.3.1 Oral Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4 Injectable
6.4.1 Injectable Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5 Topical
6.5.1 Topical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7 Animal Drug Compounding Market: Dosage Form Estimates & Trend Analysis, 2018 - 2030 (USD Million)
7.1 Dosage Form Market Share Analysis, 2022 & 2030
7.2 Animal Drug Compounding Market: Dosage Form Key Takeaways, 2018 To 2030
7.3 Suspensions
7.3.1 Suspensions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4 Solutions
7.4.1 Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5 Capsules
7.5.1 Capsules Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Animal Drug Compounding Market: Regional Market Estimates & Trend Analysis, 2018 - 2030 (USD Million)
8.1 Regional Market Share Analysis, 2022 & 2030
8.2 Regional Market Snapshot
8.3 North America
8.3.1 Swot Analysis:
8.3.1.1 North America Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 Regulatory Framework
8.3.2.4 U.S. Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 Regulatory Framework
8.3.3.4 Canada Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.4 Europe
8.4.1 SWOT ANALYSIS:
8.4.1.1 Europe Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.2 U.K.
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Regulatory Framework
8.4.2.4 U.K. Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.3 Germany
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Regulatory Framework
8.4.3.4 Germany Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.4 France
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 Regulatory Framework
8.4.4.4 France Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.5 Italy
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Regulatory Framework
8.4.5.4 Italy Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.6 Spain
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Regulatory Framework
8.4.6.4 Spain Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.5 Asia Pacific
8.5.1 SWOT ANALYSIS:
8.5.1.1 Asia Pacific Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.2 Japan
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Regulatory Framework
8.5.2.4 Japan Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.3 China
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Regulatory Framework
8.5.3.4 China Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.4 India
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Regulatory Framework
8.5.4.4 India Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.5 Australia
8.5.5.1 Key Country Dynamics
8.5.5.2 Competitive Scenario
8.5.5.3 Regulatory Framework
8.5.5.4 Australia Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.6 South Korea
8.5.6.1 Key Country Dynamics
8.5.6.2 Competitive Scenario
8.5.6.3 Regulatory Framework
8.5.6.4 South Korea Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.6 Latin America
8.6.1 SWOT ANALYSIS:
8.6.1.1 Latin America Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.2 Brazil
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 Regulatory Framework
8.6.2.4 Brazil Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.3 Mexico
8.6.3.1 Key Country Dynamics
8.6.3.2 Competitive Scenario
8.6.3.3 Regulatory Framework
8.6.3.4 Mexico Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.7 MEA
8.7.1 SWOT ANALYSIS:
8.7.1.1 MEA Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.2 South Africa
8.7.2.1 Key Country Dynamics
8.7.2.2 Competitive Scenario
8.7.2.3 Regulatory Framework
8.7.2.4 South Africa Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.3 Saudi Arabia
8.7.3.1 Key Country Dynamics
8.7.3.2 Competitive Scenario
8.7.3.3 Regulatory Framework
8.7.3.4 Saudi Arabia Animal Drug Compounding Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9 Animal Drug Compounding Market - Competitive Landscape
9.1 Market Participant Categorization
9.2 Company Profiles
- WEDGEWOOD PHARMACY
- Vimian
- Pharmaca.
- Akina Animal Health
- Triangle Compounding.
- Davis Islands Pharmacy and Compounding Lab
- Custom Med Compounding Pharmacy
- Central Compounding Center South.
- Wellness Pharmacy of Cary.
- Miller's Pharmacy
9.2.2 Financial Performance
9.2.3 Product/Service Benchmarking
9.2.4 Strategy Mapping
9.3 Estimated Company Market Share Analysis, 2022
9.4 List of Other Key Market Players
List of Tables
List of Table
Table 1 List of secondary sources
Table 2 List of key companies
Table 3 Global Animal Drug Compounding Market, by region, 2018 - 2030 (USD Million)
Table 4 Global Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 5 Global Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 6 Global Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 7 Global Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 8 North America Animal Drug Compounding Market, by country, 2018 - 2030 (USD Million)
Table 9 North America Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 10 North America Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 11 North America Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 12 North America Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 13 U.S. Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 14 U.S. Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 15 U.S. Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 16 U.S. Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 17 Canada Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 18 Canada Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 19 Canada Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 20 Canada Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 21 Europe Animal Drug Compounding Market, by country, 2018 - 2030 (USD Million)
Table 22 Europe Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 23 Europe Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 24 Europe Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 25 Europe Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 26 Germany Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 27 Germany Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 28 Germany Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 29 Germany Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 30 U.K. Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 31 U.K. Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 32 U.K. Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 33 U.K. Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 34 France Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 35 France Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 36 France Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 37 France Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 38 Italy Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 39 Italy Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 40 Italy Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 41 Italy Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 42 Spain Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 43 Spain Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 44 Spain Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 45 Spain Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Animal Drug Compounding Market, by country, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 51 Japan Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 52 Japan Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 53 Japan Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 54 Japan Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 55 China Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 56 China Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 57 China Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 58 China Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 59 India Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 60 India Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 61 India Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 62 India Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 63 South Korea Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 64 South Korea Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 65 South Korea Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 66 South Korea Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 67 Australia Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 68 Australia Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 69 Australia Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 70 Australia Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 71 LATAM Animal Drug Compounding Market, by country, 2018 - 2030 (USD Million)
Table 72 LATAM Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 73 LATAM Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 74 LATAM Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 75 LATAM Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 76 Brazil Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 77 Brazil Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 78 Brazil Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 79 Brazil Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 80 Mexico Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 81 Mexico Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 82 Mexico Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 83 Mexico Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 84 MEA Animal Drug Compounding Market, by country, 2018 - 2030 (USD Million)
Table 85 MEA Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 86 MEA Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 87 MEA Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 88 MEA Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 89 South Africa Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 90 South Africa Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 91 South Africa Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 92 South Africa Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 93 Saudi Arabia Animal Drug Compounding Market, by animal type, 2018 - 2030 (USD Million)
Table 94 Saudi Arabia Animal Drug Compounding Market, by product, 2018 - 2030 (USD Million)
Table 95 Saudi Arabia Animal Drug Compounding Market, by route of administration, 2018 - 2030 (USD Million)
Table 96 Saudi Arabia Animal Drug Compounding Market, by dosage form, 2018 - 2030 (USD Million)
Table 97 Saudi Arabia Animal Drug Compounding Market, by type, 2018 - 2030 (USD Million)
Table 98 Saudi Arabia Animal Drug Compounding Market, by application, 2018 - 2030 (USD Million)
Table 99 Saudi Arabia Animal Drug Compounding Market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Parent Market Analysis
Fig. 10 Commodity flow analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Competitive landscape snapshot
Fig. 14 Animal Drug Compounding Market Dynamics
Fig. 15 Animal Drug Compounding Market: PORTER’s Analysis
Fig. 16 Animal Drug Compounding Market PESTLE Analysis
Fig. 17 Animal Drug Compounding Market: Animal type movement analysis
Fig. 18 Animal Drug Compounding Market: Animal type Key takeaways
Fig. 19 Global companion animals market 2018 - 2030 (USD Million)
Fig. 20 Global dogs market 2018 - 2030 (USD Million)
Fig. 21 Global cats animals market 2018 - 2030 (USD Million)
Fig. 22 Global other animals market 2018 - 2030 (USD Million)
Fig. 23 Global livestock animals market 2018 - 2030 (USD Million)
Fig. 24 Animal Drug Compounding Market: Product movement analysis
Fig. 25 Animal Drug Compounding Market: product Key takeaways
Fig. 26 Global anti-infective agents market 2018 - 2030 (USD Million)
Fig. 27 Global anti-inflammatory agents market 2018 - 2030 (USD Million)
Fig. 28 Global hormone & substitutes market 2018 - 2030 (USD Million)
Fig. 29 Global CNS agents market 2018 - 2030 (USD Million)
Fig. 30 Global Other product markets 2018 - 2030 (USD Million)
Fig. 31 Animal Drug Compounding Market: Route of administration movement analysis
Fig. 32 Animal Drug Compounding Market: Route of administration Key takeaways
Fig. 33 Global oral market 2018 - 2030 (USD Million)
Fig. 34 Global injectable market 2018 - 2030 (USD Million)
Fig. 35 Global topical market 2018 - 2030 (USD Million)
Fig. 36 Global others market 2018 - 2030 (USD Million)
Fig. 37 Animal Drug Compounding Market: Dosage Form movement analysis
Fig. 38 Animal Drug Compounding Market: Dosage Form Key takeaways
Fig. 39 Global suspensions market 2018 - 2030 (USD Million)
Fig. 40 Global solutions market 2018 - 2030 (USD Million)
Fig. 41 Global capsules market 2018 - 2030 (USD Million)
Fig. 42 Regional outlook, 2022 & 2030
Fig. 43 Regional marketplace: Key takeaways
Fig. 44 North America Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 45 U.S. Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 46 Canada Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 47 Europe Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 48 Germany Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 49 U.K. Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 50 France Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 51 Italy Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 52 Spain Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 54 China Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 55 Japan Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 56 India Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 57 Australia Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 58 South Korea Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 59 Latin America Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 60 Brazil Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 61 Mexico Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 62 MEA Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 63 South Africa Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 64 Saudi Arabia Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Companies Mentioned
- WEDGEWOOD PHARMACY
- Vimian
- Pharmaca.
- Akina Animal Health
- Triangle Compounding.
- Davis Islands Pharmacy and Compounding Lab
- Custom Med Compounding Pharmacy
- Central Compounding Center South.
- Wellness Pharmacy of Cary.
- Miller's Pharmacy
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | March 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.3 Billion |
| Forecasted Market Value ( USD | $ 2.5 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
